Which has grown faster, BCRX or VCEL?

Over the past five years, BCRX grew revenue faster — BCRX at a 64.07% CAGR versus VCEL at 15.11%.

Is BCRX or VCEL more profitable?

VCEL runs the higher net margin — BCRX at -40.90% versus VCEL at 7.91%.

How have BCRX and VCEL total returns compared?

Over the past 10 years, BCRX delivered 5.82% and VCEL delivered 30.18% annualized total return. Past performance doesn't predict future results.

BioCryst Pharmaceuticals, Inc. (BCRX) vs Vericel Corporation (VCEL)

A side-by-side comparison of BioCryst Pharmaceuticals, Inc. and Vericel Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BCRX

BioCryst Pharmaceuticals, Inc.

$2.02B

$7.95HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VCEL

Vericel Corporation

$2.05B

$40.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BCRX vs VCEL

growth of $100 · dividends reinvested · last 10y

BCRX +78.8% (+6.0%/yr)VCEL +1341.1% (+30.6%/yr)VCEL compounded faster over this window

Log scale — wide-divergence pair

BCRX VCEL

BCRX vs VCEL: by the numbers

•VCEL is the larger company ($2.05B vs $2.02B market cap).
•VCEL is profitable (7.91% net margin) while BCRX runs a net loss (-40.90%).
•BCRX grew revenue faster over the past five years (64.07% vs 15.11% CAGR).

Metrics side by side

Valuation

Metric	BCRX	VCEL
P/E ratio	N/A	85.61
Forward P/E	N/A	74.94
PEG ratio	N/A	2.17
P/S ratio	2.15	6.70
P/B ratio	N/A	5.54
EV / EBITDA	N/A	65.14
FCF yield	17.67%	2.42%

Profitability

Metric	BCRX	VCEL
Gross margin	97.82%	74.56%
Operating margin	38.98%	5.95%
Net margin	-40.90%	7.91%
ROE	N/A	6.55%
ROIC	-89.73%	3.79%

Growth (annualized)

Metric	BCRX	VCEL
Revenue CAGR (5Y)	64.07%	15.11%
EPS CAGR (5Y)	N/A	39.14%
FCF CAGR (5Y)	N/A	14.83%
Total return CAGR (5Y)	-10.02%	-4.18%

Frequently asked

Which has grown faster, BCRX or VCEL?: Over the past five years, BCRX grew revenue faster — BCRX at a 64.07% CAGR versus VCEL at 15.11%.
Is BCRX or VCEL more profitable?: VCEL runs the higher net margin — BCRX at -40.90% versus VCEL at 7.91%.
How have BCRX and VCEL total returns compared?: Over the past 10 years, BCRX delivered 5.82% and VCEL delivered 30.18% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BCRX analysis Full VCEL analysis Interactive comparison tool

Dig into the metrics

Vericel P/E ratio BioCryst Pharmaceuticals ROE Vericel ROE BioCryst Pharmaceuticals operating margin Vericel operating margin BioCryst Pharmaceuticals revenue growth Vericel revenue growth BioCryst Pharmaceuticals free cash flow Vericel free cash flow

BioCryst Pharmaceuticals & Vericel appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.